Canadian health regulators have added new label warnings to Pradaxa, the new blood thinner. In Canada it is known as Pradax. The regulators are warning that the risk of bleeding events may be increased among patients with kidney problems. The Pradaxa warnings were announced on March 16, and recommend that…
New medical research suggest that the popular diabetes drugs Byetta and Januvia could increase the risk of pancreatitis and pancreatic cancer. In a study published this summer in the medical journal Gastroenterology, researchers from the University of California, Los Angeles (UCLA) found a nearly threefold increase in reported cases of…
A medical study published in the British medical journal, Lancet, has identified that all-metal on metal artificial hips fail more often than other designs. This confirmation has increased concerns about the implants and the researchers are calling for a ban. British experts at the world’s biggest artificial joint registry said…
Boehringer Ingelheim, the maker of Pradaxa have been cited by the Prescripton Medicines Code of Practice Authority (PMCPA), a British regulatory agency, for the information on the Pradaxa’s website. The British regulatory agency has cited Boehringer Ingelheim’s Pradaxa website for violating industry codes of conduct. It also charged the company…
Federal lawsuits against Wright Medical Technology, a manufacturer of metal-on-metal hip-replacement is now being consolidated in Multi district Litigation (MDL). Wright Medical Technology’s Conserve Plus implants are under assault for causing injuries similar to those produced by the DePuy ASR and Pinnacle metal on metal hip system. This is one…
Bleeding side effects in patients treated with Pradaxa have led a group of New Zealand hematologists to sound the alarm and call for better doctor education. The hematologists wrote of their concerns in a letter published in the March 1 issue of the New England Journal of Medicine. In a…
DALLAS, TEXAS: Dr Shezad Malik Law Firm, a national plaintiff’s pharmaceutical law firm, has begun an investigation against the manufacturers and distributors of Pradaxa(R), a medication that was approved to reduce the risk of strokes in high-risk cardiac patients. The drug was approved for use in the United States in…
According to Cleveland Clinic researchers, Pradaxa patients taking the new anti-clotting drug Pradaxa have a 33% higher risk of heart attack or severe symptoms of heart disease than do patients taking warfarin. This finding, from Ken Uchino, MD, and Adrian V. Hernandez, MD, PhD, is based on data from seven…
U.S. District Judge Danny Reeves, has dismissed generic Darvon and Darvocet lawsuits. A recent US Supreme Court decision shields generic drug makers from responsibility to warn patients and doctors about the dangers of associated with generic copies of brand name medications they manufacture and sell. The dismissals were based on…
Taking Pradaxa, are you playing Russian Roulette with a potentially lethal drug? Is it the case of Head you lose, Tails you lose? Taking your life into your hands should not come down to a flip of the coin. There is no antidote or treatment to reverse the bleeding side…